Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

Detalles Bibliográficos
Autores principales: Tan, Wan-Ling, Ng, Quan Sing, Lim, Cindy, Tan, Eng Huat, Toh, Chee Keong, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Tan, Daniel S. W., Lim, Darren Wan-Teck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304773/
https://www.ncbi.nlm.nih.gov/pubmed/30583726
http://dx.doi.org/10.1186/s12885-018-5215-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304773/
https://www.ncbi.nlm.nih.gov/pubmed/30583726
http://dx.doi.org/10.1186/s12885-018-5215-7

Ejemplares similares